BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32999046)

  • 1. Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy
    Ganaie AA; Mansini AP; Hussain T; Rao A; Siddique HR; Shabaneh A; Ferrari MG; Murugan P; Klingelhöfer J; Wang J; Ambartsumian N; Warlick CA; Konety BR; Saleem M
    Mol Cancer Ther; 2020 Dec; 19(12):2598-2611. PubMed ID: 32999046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
    Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
    BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide.
    Stewart RL; Carpenter BL; West DS; Knifley T; Liu L; Wang C; Weiss HL; Gal TS; Durbin EB; Arnold SM; O'Connor KL; Chen M
    Oncotarget; 2016 Jun; 7(23):34630-42. PubMed ID: 27127879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of S100A4 for bone metastasis in prostate cancer cells.
    Kim B; Jung S; Kim H; Kwon JO; Song MK; Kim MK; Kim HJ; Kim HH
    BMC Cancer; 2021 Feb; 21(1):137. PubMed ID: 33549040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-Up Biomarkers in the Evolution of Prostate Cancer, Levels of
    Alvarez-Cubero MJ; Arance E; de Santiago E; Sanchez P; Sepúlveda MR; Marrero R; Lorente JA; Gonzalez-Cabezuelo JM; Cuenca-Lopez S; Cozar JM; Vazquez-Alonso F; Martinez-Gonzalez LJ
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance.
    Jia F; Liu M; Li X; Zhang F; Yue S; Liu J
    World J Surg Oncol; 2019 Sep; 17(1):163. PubMed ID: 31526392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.
    Akiyama N; Hozumi H; Isayama T; Okada J; Sugiura K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respirology; 2020 Jul; 25(7):743-749. PubMed ID: 31597225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer.
    Kagimoto A; Tsutani Y; Kushitani K; Kambara T; Mimae T; Miyata Y; Takeshima Y; Okada M
    BMC Pulm Med; 2021 Jun; 21(1):186. PubMed ID: 34078355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model.
    Saleem M; Adhami VM; Ahmad N; Gupta S; Mukhtar H
    Clin Cancer Res; 2005 Jan; 11(1):147-53. PubMed ID: 15671539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing of ingenol mebutate for treating human colorectal cancer by targeting S100 calcium-binding protein A4 (S100A4).
    Hsieh YY; Cheng YW; Wei PL; Yang PM
    Toxicol Appl Pharmacol; 2022 Aug; 449():116134. PubMed ID: 35724704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
    Egeland EV; Boye K; Park D; Synnestvedt M; Sauer T; ; Naume B; Borgen E; Mælandsmo GM
    Breast Cancer Res Treat; 2017 Feb; 162(1):127-137. PubMed ID: 28058579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
    Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
    Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
    Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of S100A4 Predicts Migration, Invasion, and Poor Prognosis of Hypopharyngeal Squamous Cell Carcinoma.
    Xu J; Gross N; Zang Y; Cao S; Yang F; Yang Z; Yu W; Lei D; Pan X
    Mol Diagn Ther; 2019 Jun; 23(3):407-417. PubMed ID: 30868407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of S100A4 protein may be associated with the development and progression of pancreatic cancer.
    Zhou Y; Li Z; Ding Y; Zhang J; Yang Q; Wu Y
    J Cancer Res Ther; 2018; 14(Supplement):S159-S166. PubMed ID: 29578167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The S100A4 Oncoprotein Promotes Prostate Tumorigenesis in a Transgenic Mouse Model: Regulating NFκB through the RAGE Receptor.
    Siddique HR; Adhami VM; Parray A; Johnson JJ; Siddiqui IA; Shekhani MT; Murtaza I; Ambartsumian N; Konety BR; Mukhtar H; Saleem M
    Genes Cancer; 2013 May; 4(5-6):224-34. PubMed ID: 24069509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma.
    Gupta S; Hussain T; MacLennan GT; Fu P; Patel J; Mukhtar H
    J Clin Oncol; 2003 Jan; 21(1):106-12. PubMed ID: 12506178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.
    Boye K; Jacob H; Frikstad KA; Nesland JM; Maelandsmo GM; Dahl O; Nesbakken A; Flatmark K
    Cancer Med; 2016 Aug; 5(8):1840-9. PubMed ID: 27273130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice.
    Forst B; Hansen MT; Klingelhöfer J; Møller HD; Nielsen GH; Grum-Schwensen B; Ambartsumian N; Lukanidin E; Grigorian M
    PLoS One; 2010 Apr; 5(4):e10374. PubMed ID: 20442771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.